According to the manufacturer, Novo Nordisk, Wegovy can cause unpleasant gastrointestinal side effects, like nausea, vomiting, diarrhea, and stomach pain, and may result in hypoglycemia (low blood sugar) when combined with other medications that lower blood sugar, like insulin
They are probably misleadingly named and might be better termed GPX-like (Fig
GHK-Cu in Weight Loss Protocols: The Clinical Truth GHK-Cu does not cause meaningful weight loss or appetite suppression in most patients
And of course, to really seriously consider the sourcing issue that we talked about earlier
The trial enrolled adults living with obesity and without type 2 diabetes
Federal law generally prohibits the return of prescription medications to pharmacies once dispensed